Today EY announced that it plans to extend its current
Health Outcomes Assessment platform by partnering with AI company Sensyne Health and enterprise blockchain company Guardtime. The aim is to link payments to the success of clinical treatments and patient satisfaction in so-called outcomes-based contracting.
By adding AI and blockchain from the two partners EY hopes to scale the platform faster, with “fairer reimbursement” and novel treatments for patients.
“We are delighted to be working to deliver the triple win: with life sciences companies increasing access to medicines, health care providers achieving greater efficiency and effectiveness and, most importantly, more patients getting better health outcomes,” said Dan Mathews, EY EMEIA Life Sciences Leader. “This is possible through the combination of novel technologies and a supporting commercial model that allows industry collaboration.”
Article continues …
Want the full story? Pro subscribers get complete articles, exclusive industry analysis, and early access to legislative updates that keep you ahead of the competition. Join the professionals who are choosing deeper insights over surface level news.
